ARIAD Pharmaceuticals Inc (ARIA)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: ARIA Exchange: NSQ

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
2017-01-10	2017-01-09	PS Planned sale	Bollag Daniel M Sr. VP, Reg. Affairs & Quality	32,000 -19.8% 23.78 760,960 USD	32,000 -19.8%	23.78	760,960 USD
2016-10-25	2016-10-24	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	19,638 -9.0% 9.56 187,739 USD	19,638 -9.0%	9.56	187,739 USD
2016-10-05	2016-10-03	PS Planned sale	Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer	47,384 -26.8% 13.46 637,812 USD	47,384 -26.8%	13.46	637,812 USD
2016-09-28	2016-09-28	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	8,750 -3.9% 13.98 122,311 USD	8,750 -3.9%	13.98	122,311 USD
2016-09-23	2016-09-22	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	20,000 -8.7% 13.43 268,536 USD	20,000 -8.7%	13.43	268,536 USD
2016-09-16	2016-09-15	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	59,369 -20.6% 11.73 696,398 USD	59,369 -20.6%	11.73	696,398 USD
2016-08-23	2016-08-22	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	19,436 -7.8% 10.47 203,538 USD	19,436 -7.8%	10.47	203,538 USD
2016-08-15	2016-08-12	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	25,000 -9.2% 10.50 262,500 USD	25,000 -9.2%	10.50	262,500 USD
2016-07-25	2016-07-22	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	18,286 -6.9% 8.11 148,230 USD	18,286 -6.9%	8.11	148,230 USD
2016-07-05	2016-07-01	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	30,000 -10.1% 7.48 224,481 USD	30,000 -10.1%	7.48	224,481 USD
2016-07-05	2016-07-01	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	31,422 -10.5% 7.48 235,153 USD	31,422 -10.5%	7.48	235,153 USD
2016-06-29	2016-06-28	S Sale	Cole Hugh M SVP, Chief Business Officer Officer	6,012 -16.7% 7.05 42,385 USD	6,012 -16.7%	7.05	42,385 USD
2016-06-23	2016-06-22	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	23,999 -8.3% 7.28 174,638 USD	23,999 -8.3%	7.28	174,638 USD
2016-06-15	2016-06-15	S Sale	LAVIDAS ATHANESE Non-Executive Director	46,250 -26.0% 8.24 381,137 USD	46,250 -26.0%	8.24	381,137 USD
2016-06-15	2016-06-14	S Sale	LAVIDAS ATHANESE Non-Executive Director	20,000 -13.2% 8.14 162,852 USD	20,000 -13.2%	8.14	162,852 USD
2016-06-14	2016-06-14	S Sale	Radaelli Massimo Non-Executive Director	6,250 -5.6% 8.13 50,834 USD	6,250 -5.6%	8.13	50,834 USD
2016-06-15	2016-06-13	S Sale	LAVIDAS ATHANESE Non-Executive Director	10,000 -7.1% 8.21 82,050 USD	10,000 -7.1%	8.21	82,050 USD
2016-06-14	2016-06-13	S Sale	Radaelli Massimo Non-Executive Director	79,731 -43.0% 8.25 657,821 USD	79,731 -43.0%	8.25	657,821 USD
2016-06-14	2016-06-10	S Sale	Radaelli Massimo Non-Executive Director	22,588 -17.6% 8.30 187,480 USD	22,588 -17.6%	8.30	187,480 USD
2016-05-25	2016-05-23	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	17,762 -5.8% 8.08 143,430 USD	17,762 -5.8%	8.08	143,430 USD
2016-05-13	2016-05-12	B Purchase	Panayiotopoulos Paris President and CEO Executive Director	26,990 +44.2% 7.41 199,996 USD	26,990 +44.2%	7.41	199,996 USD
2016-05-02	2016-05-02	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	11,700 -3.7% 7.13 83,478 USD	11,700 -3.7%	7.13	83,478 USD
2016-04-25	2016-04-22	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	21,409 -6.8% 7.37 157,864 USD	21,409 -6.8%	7.37	157,864 USD
2016-03-23	2016-03-22	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	23,834 -7.0% 6.58 156,871 USD	23,834 -7.0%	6.58	156,871 USD
2016-03-22	2016-03-21	PS Planned sale	Haluska Frank SVP, Clinical R&D, CMO Officer	3,575 -2.4% 6.47 23,116 USD	3,575 -2.4%	6.47	23,116 USD
2016-03-22	2016-03-21	PS Planned sale	FITZGERALD EDWARD M Executive VP Officer	5,417 -1.7% 6.47 35,037 USD	5,417 -1.7%	6.47	35,037 USD
2016-03-22	2016-03-21	PS Planned sale	BERSTEIN DAVID L SVP, Chief IP Counsel Officer	2,375 -0.9% 6.47 15,356 USD	2,375 -0.9%	6.47	15,356 USD
2016-03-22	2016-03-21	PS Planned sale	Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer	4,000 -2.5% 6.47 25,871 USD	4,000 -2.5%	6.47	25,871 USD
2016-03-22	2016-03-19	PS Planned sale	Duvall Martin J EVP, CCO Officer	4,000 -4.1% 6.47 25,867 USD	4,000 -4.1%	6.47	25,867 USD
2016-03-22	2016-03-19	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	5,417 -1.6% 6.47 35,039 USD	5,417 -1.6%	6.47	35,039 USD
2016-03-22	2016-03-19	PS Planned sale	Cantor Maria E SVP, Corporate Affairs Officer	3,575 -2.6% 6.46 23,102 USD	3,575 -2.6%	6.46	23,102 USD
2016-03-03	2016-03-03	PS Planned sale	Duvall Martin J EVP, CCO Officer	9,625 -9.8% 6.12 58,863 USD	9,625 -9.8%	6.12	58,863 USD
2016-03-03	2016-03-03	PS Planned sale	Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer	9,625 -6.0% 6.11 58,852 USD	9,625 -6.0%	6.11	58,852 USD
2016-03-03	2016-03-03	PS Planned sale	Cantor Maria E SVP, Corporate Affairs Officer	9,625 -6.8% 6.12 58,869 USD	9,625 -6.8%	6.12	58,869 USD
2016-03-03	2016-03-03	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	9,625 -2.8% 6.12 58,867 USD	9,625 -2.8%	6.12	58,867 USD
2016-03-03	2016-03-03	PS Planned sale	FITZGERALD EDWARD M Executive VP, CFO Officer	9,625 -3.0% 6.12 58,866 USD	9,625 -3.0%	6.12	58,866 USD
2016-03-03	2016-03-03	PS Planned sale	Haluska Frank SVP, Clinical R&D, CMO Officer	10,588 -6.8% 6.11 64,733 USD	10,588 -6.8%	6.11	64,733 USD
2016-03-03	2016-03-03	PS Planned sale	BERSTEIN DAVID L SVP, Chief IP Counsel Officer	9,625 -3.6% 6.12 58,887 USD	9,625 -3.6%	6.12	58,887 USD
2016-03-03	2016-03-02	S Sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	25,047 -6.8% 6.00 150,282 USD	25,047 -6.8%	6.00	150,282 USD
2016-02-03	2016-02-01	PS Planned sale	Haluska Frank SVP, Clinical R&D, CMO Officer	16,133 -10.6% 4.81 77,587 USD	16,133 -10.6%	4.81	77,587 USD
2016-02-03	2016-02-01	PS Planned sale	Cantor Maria E SVP, Corporate Affairs Officer	14,667 -10.6% 4.81 70,517 USD	14,667 -10.6%	4.81	70,517 USD
2016-02-03	2016-02-01	PS Planned sale	Cantor Maria E SVP, Corporate Affairs Officer	1,466 -1.1% 4.93 7,227 USD	1,466 -1.1%	4.93	7,227 USD
2016-02-03	2016-02-01	PS Planned sale	Duvall Martin J EVP, CCO Officer	14,667 -15.6% 4.81 70,578 USD	14,667 -15.6%	4.81	70,578 USD
2016-02-03	2016-02-01	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	14,667 -4.0% 4.81 70,517 USD	14,667 -4.0%	4.81	70,517 USD
2016-02-03	2016-02-01	PS Planned sale	Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer	14,667 -9.4% 4.81 70,548 USD	14,667 -9.4%	4.81	70,548 USD
2016-02-03	2016-02-01	PS Planned sale	BERSTEIN DAVID L SVP, Chief IP Counsel Officer	14,667 -5.5% 4.81 70,515 USD	14,667 -5.5%	4.81	70,515 USD
2016-02-03	2016-02-01	PS Planned sale	FITZGERALD EDWARD M Executive VP, CFO Officer	14,667 -4.6% 4.81 70,515 USD	14,667 -4.6%	4.81	70,515 USD
2016-02-03	2016-02-01	B Purchase	Panayiotopoulos Paris President and CEO Executive Director	61,099 +inf% 4.91 299,996 USD	61,099 +inf%	4.91	299,996 USD
2015-09-28	2015-09-28	PS Planned sale	Cantor Maria E SVP, Corporate Affairs Officer	5,000 -4.4% 6.47 32,327 USD	5,000 -4.4%	6.47	32,327 USD
2015-09-28	2015-09-28	PS Planned sale	FITZGERALD EDWARD M Executive VP, CFO Officer	8,750 -2.9% 6.46 56,551 USD	8,750 -2.9%	6.46	56,551 USD
2015-09-28	2015-09-28	PS Planned sale	BERSTEIN DAVID L SVP, Chief IP Counsel Officer	5,000 -2.0% 6.46 32,316 USD	5,000 -2.0%	6.46	32,316 USD
2015-09-28	2015-09-28	PS Planned sale	Duvall Martin J EVP, CCO Officer	5,000 -7.2% 6.46 32,317 USD	5,000 -7.2%	6.46	32,317 USD
2015-09-28	2015-09-28	S Sale	Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer	5,000 -3.8% 6.46 32,316 USD	5,000 -3.8%	6.46	32,316 USD
2015-09-28	2015-09-28	PS Planned sale	Haluska Frank SVP, Clinical R&D, CMO Officer	5,500 -4.3% 6.46 35,503 USD	5,500 -4.3%	6.46	35,503 USD
2015-09-28	2015-09-28	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	8,750 -2.6% 6.46 56,560 USD	8,750 -2.6%	6.46	56,560 USD
2015-07-16	2015-07-16	PS Planned sale	Haluska Frank SVP, Clinical R&D, CMO Officer	4,400 -3.6% 8.54 37,575 USD	4,400 -3.6%	8.54	37,575 USD
2015-07-16	2015-07-16	PS Planned sale	Duvall Martin J EVP, CCO Officer	1,400 -2.3% 8.54 11,956 USD	1,400 -2.3%	8.54	11,956 USD
2015-07-16	2015-07-16	PS Planned sale	FITZGERALD EDWARD M Executive VP, CFO Officer	7,000 -2.2% 8.54 59,793 USD	7,000 -2.2%	8.54	59,793 USD
2015-07-16	2015-07-16	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	7,000 -2.1% 8.54 59,797 USD	7,000 -2.1%	8.54	59,797 USD
2015-07-16	2015-07-16	PS Planned sale	Cantor Maria E SVP, Corporate Affairs Officer	4,000 -3.5% 8.54 34,162 USD	4,000 -3.5%	8.54	34,162 USD
2015-07-16	2015-07-16	PS Planned sale	BERSTEIN DAVID L SVP, Chief IP Counsel Officer	4,000 -1.7% 8.54 34,162 USD	4,000 -1.7%	8.54	34,162 USD
2015-07-16	2015-07-16	PS Planned sale	Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer	4,000 -3.2% 8.54 34,164 USD	4,000 -3.2%	8.54	34,164 USD
2015-05-04	2015-05-01	PS Planned sale	FITZGERALD EDWARD M Executive VP, CFO Officer	60,000 -16.4% 8.80 528,000 USD	60,000 -16.4%	8.80	528,000 USD
2015-03-23	2015-03-23	PS Planned sale	BERSTEIN DAVID L SVP, Chief IP Counsel Officer	2,000 -1.2% 8.56 17,118 USD	2,000 -1.2%	8.56	17,118 USD
2015-03-23	2015-03-23	PS Planned sale	Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer	3,000 -2.5% 8.55 25,661 USD	3,000 -2.5%	8.55	25,661 USD
2015-03-23	2015-03-23	PS Planned sale	FITZGERALD EDWARD M Executive VP, CFO Officer	4,167 -1.3% 8.55 35,630 USD	4,167 -1.3%	8.55	35,630 USD
2015-03-23	2015-03-23	PS Planned sale	Duvall Martin J EVP, CCO Officer	834 -1.5% 8.57 7,145 USD	834 -1.5%	8.57	7,145 USD
2015-03-23	2015-03-23	PS Planned sale	Haluska Frank SVP, Clinical R&D, CMO Officer	3,300 -2.8% 8.55 28,229 USD	3,300 -2.8%	8.55	28,229 USD
2015-03-23	2015-03-23	PS Planned sale	Cantor Maria E SVP, Corporate Affairs and HR Officer	4,033 -3.7% 8.55 34,491 USD	4,033 -3.7%	8.55	34,491 USD
2015-03-23	2015-03-23	PS Planned sale	CLACKSON TIMOTHY P President, R&D, CSO Officer	6,667 -1.5% 8.55 57,016 USD	6,667 -1.5%	8.55	57,016 USD
2015-03-23	2015-03-20	PS Planned sale	BERSTEIN DAVID L SVP, Chief IP Counsel Officer	2,375 -1.5% 8.85 21,026 USD	2,375 -1.5%	8.85	21,026 USD
2015-03-23	2015-03-20	PS Planned sale	Bollag Daniel M Sr. VP, Reg. Affairs & Quality Officer	4,000 -3.4% 8.85 35,390 USD	4,000 -3.4%	8.85	35,390 USD
2015-03-23	2015-03-20	PS Planned sale	FITZGERALD EDWARD M Executive VP, CFO Officer	5,417 -1.8% 8.84 47,908 USD	5,417 -1.8%	8.84	47,908 USD
2015-03-23	2015-03-20	PS Planned sale	Duvall Martin J EVP, CCO Officer	4,000 -6.9% 8.85 35,381 USD	4,000 -6.9%	8.85	35,381 USD
2015-03-23	2015-03-20	PS Planned sale	Haluska Frank SVP, Clinical R&D, CMO Officer	3,575 -3.1% 8.85 31,634 USD	3,575 -3.1%	8.85	31,634 USD